Understanding the Surge in Vaping Among New Zealand Youth

New Zealand has seen a sharp rise in vaping, particularly among younger demographics. According to recent health surveys, more than 22 percent of individuals aged 15 to 24 regularly vape, surpassing traditional cigarette use in this group. This trend raises alarms as long-term effects remain understudied, prompting researchers at the University of Canterbury to delve into the potential health hazards posed by electronic cigarette aerosols, commonly referred to as vape smoke.

The popularity of vaping stems from perceptions of it as a safer alternative to smoking, flavored options appealing to teens, and aggressive marketing. However, with disposable vapes banned since June 2025 and flavor restrictions in place, sales have dipped slightly—from $417 million in 2024 to $401 million in 2025 among under-35s—yet enforcement challenges persist, including vape stores in low-income areas skirting rules.

University of Canterbury's Groundbreaking Analysis

Led by toxicology expert Professor Ian Shaw from the School of Physical and Chemical Sciences at the University of Canterbury, a team including postgraduate students examined the chemical makeup of vape smoke. Published on April 17, 2026, in the New Zealand Medical Journal, their viewpoint article titled "Is it safe to vape? Assessing the carcinogenic risk of ‘vape smoke’" combines chemistry with toxicology data.

They focused on propylene glycol (PG) and vegetable glycerin (VG), the primary solvents in e-liquids, which vaporize when heated in devices to 190°C on average. Nicotine and flavors are added, but heating triggers thermal decomposition into aldehydes—known irritants and potential carcinogens. The risk assessment formula used was straightforward: RISK = HAZARD × EXPOSURE, drawing from animal inhalation studies and measured concentrations in mcg per puff.

Key Carcinogenic Chemicals in Vape Smoke

The study pinpointed several aldehydes as primary concerns:

• Formaldehyde: Classified by the International Agency for Research on Cancer (IARC) as Group 1 carcinogenic to humans. Produced at levels comparable to cigarette smoke (~5 mcg/puff), exceeding rat nasal cancer thresholds (14.3 ppm). Causes DNA-protein crosslinks, posing definite risk for nasal, oral, and lung cancers.
• Acrolein: IARC Group 2A (probably carcinogenic). Triggers respiratory hyperplasia in rats at 2 ppm; vape exposures fall within this range, depleting glutathione and promoting inflammation-linked carcinogenesis.
• Acetaldehyde: IARC Group 2B (possibly carcinogenic, linked to esophageal cancer). Doses lower than cigarette levels and detoxified efficiently, yielding low risk.
• Propionaldehyde and Methylglyoxal: Negligible risk; exposures far below thresholds, though may enhance other effects via oxidative stress.

Flavors like cinnamaldehyde contribute minimally at low concentrations, but metals from coils (e.g., chromium, nickel) add trace risks.

These chemicals arise from incomplete combustion-like reactions during vaping, mimicking but not equaling cigarette pyrolysis complexities.

Comparing Vape Smoke to Traditional Cigarette Smoke

Cigarette smoke harbors over 7,000 chemicals, including potent polycyclic aromatic hydrocarbons like benzo[a]pyrene absent in vapes. While formaldehyde doses match, acrolein and acetaldehyde are lower in vaping. Professor Shaw notes: "Vaping cancer risk is lower overall due to fewer carcinogens, but introduces unnecessary exposure for non-smokers."

Animal data shows cigarette equivalence for some aldehydes, but vapes lack tar and combustion radicals, reducing total potency. Thus, switching smokers benefit, but youth uptake creates novel risks.

Mechanisms of Cancer Development from Vape Exposure

Beyond direct genotoxicity, aldehydes induce inflammation, accelerating cell division and mutation accumulation—a non-genotoxic pathway. Step-by-step: Heating PG/VG produces aldehydes; inhalation delivers ~90-150 mL puffs; absorption causes oxidative stress; chronic exposure promotes hyperplasia, potentially leading to squamous cell carcinomas in airways/oral cavity.

Rodent studies confirm nasal tumors from formaldehyde at vape-like doses, while acrolein exacerbates via glutathione depletion, impairing detoxification. Synergistic effects amplify risks over time.

Limitations of the Research and Calls for Long-Term Data

Shaw acknowledges no epidemiological human evidence yet—cancers manifest after 15+ years. Variability in devices (coil temps 157-266°C, voltages) yields inconsistent exposures. Detox pathways like aldehyde dehydrogenase mitigate some risks, unquantified here. Future needs: cohort studies tracking vapers for cancer incidence.

Expert Perspectives and Broader Scientific Consensus

Associate Professor George Laking (University of Auckland) concurs risks exist but pale beside cigarettes; contextualize against daily hazards like alcohol. Andrew Waa (University of Otago) stresses protecting youth, where vaping renormalizes nicotine without cessation benefits.

Globally, a March 2026 UNSW review echoes findings, citing DNA damage and mouse lung cancers from vapes.UNSW vaping cancer review Vaping Industries Association cautions against overinterpreting mechanistic data sans human outcomes.

New Zealand's Evolving Vaping Policies

Post-2025 Smokefree reforms banned disposables, restricted flavors/sales to specialist stores, and mandated plain packaging. Youth daily vaping hit 18.6% pre-ban; surveys show modest declines. Enforcement ramps up, e.g., Gisborne fining violators. Study bolsters calls for youth safeguards amid 401 million vape sales.RNZ coverage of UC study

Practical Advice: Quitting Vaping and Seeking Support

For smokers, vaping aids cessation, netting harm reduction. Non-smokers/youth: avoid entirely. Cessation steps: Consult Quitline (0800 778 778), nicotine patches/gum, behavioral therapy. UC's ASPIRE centre researches dual quitting aids. Track progress via apps; combine with exercise for inflammation reduction.

• Assess dependence: Daily puffs? Cravings?
• Gradual taper or cold turkey with support.
• Monitor oral/lung health annually.

Implications for Toxicology Research Careers in New Zealand

Studies like Shaw's highlight demand for toxicologists at unis like Canterbury. Roles involve chemical analysis, risk modeling, policy advising. Entry: BSc Chemistry/Toxicology, MSc/PhD for research. UC offers programs fostering such work; opportunities in govt labs, pharma.Science Media Centre expert reactions

Photo by Davide Sibilio on Unsplash

Future Outlook: Monitoring Vaping's Long-Term Impact

As NZ's ~400k vapers age, epi studies will quantify risks by 2040. Tech advances like biomarkers may accelerate insights. Policy may tighten youth access, fund cessation. UC's work positions NZ as leader in vape toxicology, urging balanced harm reduction.